TrialHaematologica2015

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.

Elisa J Pulczynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.